References
- Cutbush M, Mollison PL. The Duffy blood group system. Heredity 1950;4:383–9.
- Cutbush M, Mollison PL, Parkin DM. A new human blood group. Nature 1950;165:188–9.
- Ikin EW, Mourant AE, Pettenkofer JH, Blumenthal G. Discovery of the expected haemagglutinin, anti-Fyb. Nature 1951;168:1077–8.
- Donahue RP, Bias WB, Renwick JH, McKusick VA. Probable assignment of the Duffy blood group locus to chromosome 1 in man. Proc Natl Acad Sci U S A 1968;61:949–55.
- Pogo AO, Chaudhuri A. The Duffy protein: a malarial and chemokine receptor. Semin Hematol 2000;37:122–9.
- Daniels G. Duffy blood group system. In: Human blood groups. 2nd ed. Malden, MA: Blackwell Science, 2002:324–41.
- Daniels G. Terminology for blood groups. Available at: http://ibgrl.blood.co.uk/ISBTPages/AlleleTerminology/Allele-Terminology.htm. (last accessed 05/23/2010).
- Tournamille C, Colin Y, Cartron JP, Le Van Kim C. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995;10:224–8.
- Albrey JA, Vincent EE, Hutchinson J, et al. A new antibody, anti-Fy3, in the Duffy blood group system. Vox Sang 1971;20:29–35.
- Mallinson G, Soo KS, Schall TJ, Pisacka M, Anstee DJ. Mutations in the erythrocyte chemokine receptor (Duffy) gene: the molecular basis of the Fya/Fyb antigens and identification of a deletion in the Duffy gene of an apparently healthy individual with the Fy(a-b-) phenotype. Br J Haematol 1995;90:823–9.
- Rios M, Chaudhuri A, Mallinson G, et al. New genotypes in Fy(a-b-) individuals: nonsense mutations (Trp to stop) in the coding sequence of either FY A or FY B. Br J Haematol 2000;108:448–54.
- Chown B, Lewis M, Kaita H. The Duffy blood group system in Caucasians: evidence for a new allele. Am J Hum Genet 1965;17:384–9.
- Olsson ML, Smythe JS, Hansson C, et al. The Fyx phenotype is associated with a missense mutation in the Fyb allele predicting Arg89Cys in the Duffy glycoprotein. Br J Haematol 1998;103:1184–91.
- Gassner C, Kraus RL, Dovc T, et al. Fyx is associated with two missense point mutations in its gene and can be detected by PCR-SSP. Immunohematology 2000;16:61–7.
- Klein HG, Anstee DJ. Mollison’s blood transfusion in clinical medicine. 11th ed. Malden, MA: Blackwell Publishing, 2005.
- Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, NC: Montgomery Scientific Publications, 1998.
- Vengelen-Tyler V. Anti-Fya preceding anti-Fy3 or -Fy5: a study of five cases (abstract). Transfusion 1985;25:482.
- Le Pennec PY, Rouger P, Klein MT, Robert N, Salmon C. Study of anti-Fya in five black Fy(a-b-) patients. Vox Sang 1987;52:246–9.
- Geifman-Holtzman O, Wojtowycz M, Kosmas E, Artal R. Female alloimmunization with antibodies known to cause hemolytic disease. Obstet Gynecol 1997;89:272–5.
- Hughes LH, Rossi KQ, Krugh DW, O’Shaughnessy RW. Management of pregnancies complicated by anti-Fy(a) alloimmunization. Transfusion 2007;47:1858–61.
- Vescio LA, Fariña D, Rogido M, Sóla A. Hemolytic disease of the newborn caused by anti-Fyb. (Letter) Transfusion 1987;27:366.
- Olteanu H, Gerber D, Partridge K, Sarode R. Acute hemolytic transfusion reaction secondary to anti-Fy3. Immunohematology 2005;21:48–52.
- Went R, Wright J, Webster R, Stamps R. Anti-Fy3 in sickle cell disease: a difficult transfusion problem. Br J Haematol 2009;144:621–2.
- Behzad O, Lee CL, Gavin J, Marsh WL. A new anti-erythrocyte antibody in the Duffy system: anti-Fy4. Vox Sang 1973;24:337–42.
- Colledge KI, Pezzulich M, Marsh WL. Anti-Fy5, an antibody disclosing a probable association between the Rhesus and Duffy blood group genes. Vox Sang 1973;24:193–9.
- Bowen DT, Devenish A, Dalton J, Hewitt PE. Delayed haemolytic transfusion reaction due to simultaneous appearance of anti-Fya and anti-Fy5. Vox Sang 1988;55:35–6.
- Chan-Shu SA. The second example of anti-Duffy5. Transfusion 1980;20:358–60.
- Waśniowska K, Blanchard D, Janvier D, et al. Identification of the Fy6 epitope recognized by two monoclonal antibodies in the N-terminal extracellular portion of the Duffy antigen receptor for chemokines. Mol Immunol 1996;33:917–23.
- Wasniowska K, Petit-LeRoux Y, Tournamille C, et al. Structural characterization of the epitope recognized by the new anti-Fy6 monoclonal antibody NaM 185-2C3. Transfus Med 2002;12:205–11.
- Wasniowska K, Lisowska E, Halverson GR, Chaudhuri A, Reid ME. The Fya, Fy6 and Fy3 epitopes of the Duffy blood group system recognized by new monoclonal antibodies: identification of a linear Fy3 epitope. Br J Haematol 2004;124:118–22.
- Iwamoto S, Li J, Omi T, Ikemoto S, Kajii E. Identification of a novel exon and spliced form of Duffy mRNA that is the predominant transcript in both erythroid and postcapillary venule endothelium. Blood 1996;87:378–85.
- Westhoff CM, Reid ME. Review: the Kell, Duffy, and Kidd blood group systems. Immunohematology 2004;20:37–49.
- Chaudhuri A, Zbrzezna V, Johnson C, et al. Purification and characterization of an erythrocyte protein complex carrying Duffy blood group antigenicity. Possible receptor for Plasmodium vivax and Plasmodium knowlesi malaria parasite. J Biol Chem 1989;264:13770–4.
- Yazdanbakhsh K, Rios M, Storry JR, et al. Molecular mechanisms that lead to reduced expression of Duffy antigens. Transfusion 2000;40:310–20.
- Lu ZH, Wang ZX. Horuk R, et al. The promiscuous chemokine binding profile of the Duffy antigen/receptor for chemokines is primarily localized to sequences in the amino-terminal domain. J Biol Chem 1995;270:26239–45.
- Toumamille C, Le Van Kim C, Gane P, Cartron JP, Colin Y. Molecular basis and PCR-DNA typing of the Fya/fyb blood group polymorphism. Hum Genet 1995;95:407–10.
- Ferreira R, Ohneda K, Yamamoto M, Philipsen S. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol Cell Biol 2005;25:1215–27.
- Zimmerman PA, Wooley I, Masinde GL, et al. Emergence of FY*Anull in a Plasmodiumvivax-endemic region of Papua New Guinea. Proc Natl Acad Sci U S A 1999;96:13973–7.
- Chaudhuri A, Polyakova J, Zbrzezna V, Pogo AO. The coding sequence of Duffy blood group gene in humans and simians: restriction fragment length polymorphism, antibody and malarial parasite specificities, and expression in nonerythroid tissues in Duffy-negative individuals. Blood 1995;85:615–21.
- Rot A, von Andrian UH. Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 2004;22:891–928.
- Horuk R, Chitnis CE, Darbonne WC, et al. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 1993;261:1182–4.
- Pruenster M, Rot A. Throwing light on DARC. Biochem Soc Trans 2006;34:1005–8.
- Darbonne WC, Rice GC, Mohler MA. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362–9.
- Liu XH, Hadley TJ, Xu L, Peiper SC, Ray PE. Up-regulation of Duffy antigen receptor expression in children with renal disease. Kidney Int 1999;55:1491–500.
- Akalin E, Neylan JF. The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003;75:1496–500.
- Mange KC, Prak EL, Kamoun M, et al. Duffy antigen receptor and genetic susceptibility of African Americans to acute rejection and delayed function. Kidney Int 2004;66:1187–92.
- Lerut E, Van Damme B, Noizat-Pirenne F, et al. Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion 2007;47:28–40.
- Miller LH, Mason SJ, Clyde DF, McGinniss MH. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976;295:302–4.
- King CL, Michon P, Shakri AR, et al. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc Natl Acad Sci U S A 2008;105:8363–8.
- Langhi DM Jr, Bordin JO. Duffy blood group and malaria. Hematology 2006;11:389–98.
- Goodrick MJ, Hadley AG, Poole G. Haemolytic disease of the fetus and newborn due to anti-Fy(a) and the potential clinical value of Duffy genotyping in pregnancies at risk. Transfus Med 1997;7:301–4.
- Westhoff CM, Sloan SR. Molecular genotyping in transfusion medicine. Clin Chem 2008;54:1948–50.
- Castilho L. The value of DNA analysis for antigens in the Duffy blood group system. Transfusion 2007;47(Suppl):28S–31S.
- He W, Neil S, Kulkarni H, et al. Duffy antigen receptor for chemokines mediates trans-infection of HIV-1 from red blood cells to target cells and affects HIV-AIDS susceptibility. Cell Host Microbe 2008;4:52–62.
- Shen H, Schuster R, Stringer KF, Waltz SE, Lentsch AB. The Duffy antigen/receptor for chemokines (DARC) regulates prostate tumor growth. FASEB J 2006;20:59–64.